Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2004Haemophilia

The economic impact of factor VIII inhibitors in patients with haemophilia

View Full Paper
Ask AI
Bookmark
Share

Authors

RBRhonda L. BohnCorban UniversityLALouis M. AledortIcahn School of Medicine at Mount SinaiKPKathleen PutnamBrigham and Women's Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bohn et al. (2004) studied this question.

synapsesocial.com/papers/6a9484b28e46f26e6900feeehttps://doi.org/10.1046/j.1365-2516.2003.00849.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The impact of inhibitors on the cost of clotting factor replacement therapy in haemophilia A in Canada1999 · 37 citations
  2. 2Mortality in Patients with Hemophilia: Changes in a Dutch Population from 1986 to 1992 and 1973 to 19861995 · 167 citations
  3. 3Immune tolerance induction in hemophilia patients with inhibitors: costly can be cheaper2000 · 94 citations
  4. 4Defining the Impact of Hemophilia: The Academic Achievement in Children With Hemophilia Study2001 · 128 citations
  5. 5Immune tolerance induction in hemophilia patients with inhibitors: costly can be cheaper2000 · 29 citations